A first-in-human pilot trial suggests umbilical cord–derived mesenchymal stem cell eye drops may safely improve symptoms and inflammation in refractory dry eye, including Sjögren’s syndrome.
Figure 1: Immunomodulatory effects of simulated MSCs. MSCs utilize different molecular mechanisms to suppress (in most cases) or activate immune cells. Orange arrows: inhibition; Green arrows: ...
Global today announced the publication of its new peer-reviewed study, "Hierarchical Therapeutic Potential in the Mesenchymal Stem Cell Landscape," in the Journal of Translational Medicine. The paper ...
MSC-derived extracellular vesicles provide a novel cell-free nanotherapeutic strategy for hepatorenal syndrome and reveal a ...
The promise of mesenchymal stem cells (MSCs) to heal heart disease could be around the corner thanks to a new delivery method tested by regenerative medicine company Cynata Therapeutics Ltd.
BioCardia, Inc. announced the completion of enrollment and dosing in the low dose cohort of its Phase I/II CardiALLO™ trial, which aims to treat patients with ischemic heart failure of reduced ...
It’s harvest day at the Karolinska Institute in Stockholm. As sunshine bathes the leafy university campus, scientists inside the labs work under cool fluorescent light. Clad in green protective gear, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback